All articles — 4416 total
CIB arrives at its May 5 earnings call in a notably different posture than it did three months ago — short sellers have been covering aggressively, the borrow market is loose, and the options market is tilted decidedly…
ITUB approaches its May 5 earnings release with short sellers pulling back and the stock posting its best monthly gain in recent memory. The most notable shift in positioning is on the short side. Short interest…
AMETEK heads into its Q1 2026 earnings today with investors more constructive than cautious — and the data largely backs that confidence up. Options positioning is the clearest tell. The put/call ratio has eased to…
AIG enters its Q1 2026 earnings call with a notable analyst consensus shift as the backdrop — and a stock trading nearly 14% below where it started the year. The dominant pre-earnings signal is clear: Wall Street has…
American Financial Group heads into its May 1 Q1 earnings release with options traders signalling an unusually bullish lean — a contrast that cuts against the cautious macro backdrop facing property and casualty…
Agnico Eagle Mines reports today with the numbers already in — and the headline print lands cleanly on the bull side of the debate. Q1 adjusted EPS came in at $3.40, beating the Street's $3.26 consensus. Revenue of…
Aflac heads into its May 4 Q1 earnings call with the most notable pre-print signal coming not from short sellers or options traders — but from its own largest non-institutional stakeholder trimming its position. Japan…
Guardian Pharmacy Services is collecting analyst buy ratings while options traders load up on puts. The divergence sharpens with earnings just one week away. B of A Securities initiated coverage on April 27 with a Buy…
Short sellers in CUE — Cue Biopharma — have retreated sharply. They left behind a lending market under real strain. Short interest collapsed 83% in one week, falling to just 1.1% of free float. That rapid exit drove…
CABO walks into its Q1 2026 results tonight having shed more than a fifth of its value in a single week — a collapse that makes the print feel less like a catalyst and more like a reckoning. The stock closed Wednesday…
Teladoc Health enters its May 21 earnings date with a notable shift under the hood: short sellers have been covering meaningfully over the past month, even as the stock trades near multi-year lows at $5.95. The short…
WING enters the post-earnings period carrying a 10% single-week decline and a wave of analyst target cuts — the Street is still bullish in aggregate, but the numbers underneath that consensus are moving fast. The…
GKOS just delivered one of its cleanest quarters in recent memory — and the Street rewarded it immediately. Glaukos reported Q1 2026 results after the close on April 29. Adjusted EPS came in at $(0.18), sharply ahead…
Shopify heads into its May 5 Q1 earnings print carrying a 30% surge in short interest over five days — its most charged pre-earnings setup in months. The positioning story is the headline this week. Short interest…
ETSY heads into May with its most dramatic week in months, torn between a convincing earnings beat, a wave of analyst upgrades, and an executive chairman who has spent April steadily reducing his stake into every…
GDDY reports Q1 2026 results today after market close — but the market has spent the week quietly reducing its bearish positioning ahead of the print. Short sellers have been exiting. SI fell 5.4% over the week to…
INDV delivered a sharp Q1 2026 earnings beat today, setting up an unusually charged week-end for a stock that shorts have been quietly building into. Q1 adjusted EPS came in at $0.96, versus a Street estimate of $0.66.…
Floor & Decor reports Q1 2026 results today after the close, and the setup is about as cautious as it gets — shorts rebuilt through April, options traders are hedging near the top of the year, and nearly every analyst…
Axalta Coating Systems reported Q1 results this morning that cleared the bar with room to spare. Adjusted EPS came in at $0.56, six cents above the $0.50 consensus. Revenue of $1.254 billion topped estimates of $1.213…
Viking Therapeutics enters the post-earnings stretch with its heaviest short position in months still intact — even as the stock slipped further following a wider-than-expected Q1 loss. Short sellers have not blinked.…
